Article

Heterogeneity of human peripheral blood eosinophil-type colonies: Evidence for a common basophil-eosinophil progenitor

Blood (Impact Factor: 10.43). 09/1985; 66(2):312-8.
Source: PubMed

ABSTRACT We have recently shown that a proportion of previously designated human eosinophil "(Eo)-type" colonies in methylcellulose contain basophils and histamine (Denburg et al Blood 61:775, 1983). In the present studies, individual Eo-type colonies have been analyzed by cell morphology as well as by biochemical assays for histamine, Charcot-Leyden crystal protein (CLC), and eosinophil granule major basic protein (MBP). Clonal origin of single Eo-type colonies was confirmed by G6PD isoenzyme analysis. Morphological observations of such colonies revealed the existence of two distinct colony types: (1) Eo type containing 100% basophils and (2) Eo type containing mixtures of basophils and eosinophils, including cells with mixed basophil-eosinophil granulation. Histamine was not detected in pure, mature peripheral blood eosinophils. Immunofluorescent studies demonstrated bright staining for CLC and MBP in 95% +/- 3% of cells in Eo-type colonies but only in 5% +/- 4% of cells in GM-type colonies. Radioimmunoassay for MBP was positive in 5/9 Eo-type and 0/10 neutrophil-macrophage ("GM-type") colonies, with a mean level (nanogram/colony) of 11.6 +/- 4.2 per Eo-type colony; four of the latter colonies were doubly positive for both histamine and MBP. These and previous findings point out the morphological and biochemical heterogeneity of peripheral blood Eo-type colonies and provide direct evidence for the existence of a common, circulating basophil-eosinophil progenitor.

Download full-text

Full-text

Available from: Steven J Ackerman, Aug 20, 2015
0 Followers
 · 
118 Views
  • Source
    • "Hybrid eosinophilic–basophilic acute myeloid leukaemia diagnosed by electron microscopy Hybrid granulocytes containing neutrophilic, basophilic and eosinophilic granules have been demonstrated in chronic myeloid leukaemia (Weil & Hrisinko, 1987) and acute myelomonocytic leukaemia associated with inv(16)(p13q22) (Bitter et al, 1984). In vitro clonogenic assays identified eosinophilic–basophilic hybrid granulocytes in normal blood precursors, suggesting the existence of a common progenitor (Denburg et al, 1985). The present study used electron microscopy (EM) to detect the presence of eosinophilic and basophilic granules in the leukaemic blasts of a patient with acute myeloid leukaemia, subtype M1 (AML-M1). "
    British Journal of Haematology 06/2007; 137(4):381-3. DOI:10.1111/j.1365-2141.2007.06579.x · 4.96 Impact Factor
  • Source
    • "GleevecÒ is a 2-phenylaminopyrimidine tyrosine kinase inhibitor with specific activity for the Abelson tyrosine kinase (ABL), PDGFR and stem cell factor receptor (KIT). Eosinophils are derived from haematopoietic stem cells that are committed initially to the myeloid and subsequently to the basophil–eosinophil lineage (Denburg et al, 1985). Cationic proteins (major basic protein, eosinophilic cationic protein, eosinophil-derived neurotoxin, eosinophil peroxidase), cytokines (interleukins and tumour necrosis factor) and lipid mediators (leucotrienes) constitute the content of the eosinophilic granule and mediate parasite defence reaction, allergic response, tissue inflammation and immune modulation (Rothenberg & Hogan, 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Blood eosinophilia signifies either a cytokine-mediated reactive phenomenon (secondary) or an integral phenotype of an underlying haematological neoplasm (primary). Secondary eosinophilia is usually associated with parasitosis in Third World countries and allergic conditions in the West. Primary eosinophilia is operationally classified as being clonal or idiopathic, depending on the respective presence or absence of a molecular, cytogenetic or histological evidence for a myeloid malignancy. The current communication features a comprehensive clinical summary of both secondary and primary eosinophilic disorders with emphasis on recent developments in molecular pathogenesis and treatment.
    British Journal of Haematology 07/2006; 133(5):468-92. DOI:10.1111/j.1365-2141.2006.06038.x · 4.96 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Summary Granulocytes with the hybrid characteristics of eosinophils and basophils have been identified in the bone marrow and peripheral blood of humans with myeloid leukemias. We now describe a technique by which such hybrid granulocytes can be developed in vitro from normal cord blood precursors cultured in the presence of recombinant human interleukin (rhlL) 3 (350 pM) and rhlL-5 (200 pM) in a plastic vessel coated with Matrigel TM. After 14 d in culture, 90 +_ 3% (mean _+ standard error of the mean) of the nonadherent cells cultured in the Matrigel-coated flasks contained both eosinophil and basophil granules, as indicated by staining with Wright's and Giemsa stains. Of the nonadherent cells, 93 +_ 1% contained cyanide-resistant peroxidase, and 88 _+ 2% were toluidine blue-positive, characteristic of eosinophil and basophil granules, respectively. Transmission electron micrographs showed hybrid cells containing ultrastructurally distinct eosinophil granules with developing crystalline cores and basophil granules with reticular structures. These 14-d cord blood-derived cell cultures showed strong hybridization signals for eosinophil-derived neurotoxin by RNA blot analysis and contained 78 ng histamine per 106 cells. When the granulocytes were removed from cytokine-containing medium and suspended without Matrigel in RPMI 1640 medium containing 10% fetal calf serum (FCS), more than 80% of the granulocytes excluded trypan blue for as long as 5 d, and 93% had developed into eosinophils at 6 d. Conditioned medium prepared over 48 h from the 14-d cell cultures (hybrid granulocytes) sustained the 4-d viability in vitro of 78% of peripheral blood eosinophils from atopic donors. In comparison, 13 % survived in RPMI 1640 containing 10% FCS alone. This viability-sustaining activity was nearly completely neutralized by an anti-granulocyte/macrophage colony-stimulating factor (GM-CSF) antibody and was only minimally reduced by anti-IL-3 or -IL-5. Thus, cells possessing both eosinophil and basophil granules by both histochemical and ultrastructural analysis can be developed from normal progenitors in vitro in response to eosinophilopoietic cytokines and Matrigel. Their subsequent spontaneous development into mature eosinophils suggests that hybrid granulocytes are part of a normal developmental sequence during eosinophilopoiesis, Furthermore, these hybrid granulocytes are capable of autoregulation through elaboration of GM-CSF, which sustains their viability.
Show more